Biostax Corp (BTAX)

[Herold]

On July 22, 2020, director Kevin J. Phelps, interim president and CEO of Immune Therapeutics, Inc. (“Immune” or the “Company”) entered into a three-year executive employment agreement (the “Agreement”) with the Company to serve as president and CEO. This agreement was formally approved by the Company’s Board as of July 24, 2020 with Mr. Phelps abstaining. While fully effective, the parties may expand and restate the Agreement within thirty days